155 related articles for article (PubMed ID: 16487308)
1. Long-term systemic and mucosal antibody responses measured in BALB/c mice following intranasal challenge with viable enterotoxigenic Escherichia coli.
Byrd W; Cassels FJ
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):262-8. PubMed ID: 16487308
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity and immune response measured in mice following intranasal challenge with enterotoxigenic Escherichia coli strains H10407 and B7A.
Byrd W; Mog SR; Cassels FJ
Infect Immun; 2003 Jan; 71(1):13-21. PubMed ID: 12496144
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin.
Byrd W; Cassels FJ
Vaccine; 2003 May; 21(17-18):1884-93. PubMed ID: 12706673
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
5. The encapsulation of enterotoxigenic Escherichia coli colonization factor CS3 in biodegradable microspheres enhances the murine antibody response following intranasal administration.
Byrd W; Cassels FJ
Microbiology (Reading); 2006 Mar; 152(Pt 3):779-786. PubMed ID: 16514157
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers.
Carpenter CM; Hall ER; Randall R; McKenzie R; Cassels F; Diaz N; Thomas N; Bedford P; Darsley M; Gewert C; Howard C; Sack RB; Sack DA; Chang HS; Gomes G; Bourgeois AL
Vaccine; 2006 May; 24(18):3709-18. PubMed ID: 16153753
[TBL] [Abstract][Full Text] [Related]
7. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
8. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea.
Rao MR; Wierzba TF; Savarino SJ; Abu-Elyazeed R; El-Ghoreb N; Hall ER; Naficy A; Abdel-Messih I; Frenck RW; Svennerholm AM; Clemens JD
J Infect Dis; 2005 Feb; 191(4):562-70. PubMed ID: 15655780
[TBL] [Abstract][Full Text] [Related]
9. Protection of piglets against enteric colibacillosis by intranasal immunization with K88ac (F4ac) fimbriae and heat labile enterotoxin of Escherichia coli.
Lin J; Mateo KS; Zhao M; Erickson AK; Garcia N; He D; Moxley RA; Francis DH
Vet Microbiol; 2013 Mar; 162(2-4):731-739. PubMed ID: 23089483
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).
Norton EB; Branco LM; Clements JD
PLoS One; 2015; 10(8):e0136302. PubMed ID: 26305793
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Yu J; Cassels F; Scharton-Kersten T; Hammond SA; Hartman A; Angov E; Corthésy B; Alving C; Glenn G
Infect Immun; 2002 Mar; 70(3):1056-68. PubMed ID: 11854183
[TBL] [Abstract][Full Text] [Related]
14. [Simultaneous expression of CS3 colonization factor antigen and LT-B/ST fusion enterotoxin antigen of enterotoxigenic Escherichia coli by attenuated Shigella flexneri 2a].
Liu TT; Li SQ; Zhang ZS; Zheng JP; Liu XL; Luo G; Huang CF
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):49-54. PubMed ID: 12518227
[TBL] [Abstract][Full Text] [Related]
15. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.
Rollenhagen JE; Woods CM; O'Dowd A; Poole ST; Tian JH; Guebre-Xabier M; Ellingsworth L; Prouty MG; Glenn G; Savarino SJ
Vaccine; 2019 Sep; 37(42):6134-6138. PubMed ID: 31492474
[TBL] [Abstract][Full Text] [Related]
17. Intranasal immunization of BALB/c mice with enterotoxigenic Escherichia coli colonization factor CS6 encapsulated in biodegradable poly(DL-lactide-co-glycolide) microspheres.
Byrd W; Cassels FJ
Vaccine; 2006 Feb; 24(9):1359-66. PubMed ID: 16233937
[TBL] [Abstract][Full Text] [Related]
18. Preexisting antibodies to homologous colonization factors and heat-labile toxin in serum, and the risk to develop enterotoxigenic Escherichia coli-associated diarrhea.
Tobias J; Andersson K; Bialik A; Cohen D
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):229-31. PubMed ID: 17964106
[TBL] [Abstract][Full Text] [Related]
19. Detection of fecal and serum antibodies against enterotoxigenic Escherichia coli toxins and colonization factors in deployed U.S. military personnel during Operation Bright Star 2001--Egypt.
El-Mohamady H; Francis W; Shaheen HI; Rozmajzl P; Rockabrand DM; Karim AK; Hall ER; Sanders JW
Egypt J Immunol; 2006; 13(1):189-98. PubMed ID: 17974161
[TBL] [Abstract][Full Text] [Related]
20. Development of intestinal antibodies against Escherichia coli antigens in piglets with experimental neonatal E. coli diarrhoea.
Olsson E; Smyth CJ; Söderlind O; Svennerholm AM; Möllby R
Vet Microbiol; 1986 Jul; 12(2):119-33. PubMed ID: 3529605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
